FDA
-
-
-
-
-
-
-
Imagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSenseĀ® HER2 Imaging Agent
-
-
-
-
-
-
-
Imagion Biosystems Reports Progress on Regulatory Pathway
326,363 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

